Zentalis Pharmaceuticals, Inc.
USD4.80
+0.20 (+4.23%)
CEO
Julia Marie Eastland
IPO Date
2020-04-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.60
Prev. Close
$4.61
Day Low
$4.46
Day High
$4.86
52W Low
$1.13
52W High
$6.95
Market Cap
$0.34B
Volume
0.36M
| -1.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -66.8% | -52.0% | 0.10 | 7.16 | -3.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -54.6% | -42.8% | 0.11 | 7.98 | -4.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -43.6% | -33.6% | 0.13 | 7.98 | -22.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -38.2% | -32.2% | 0.01 | 12.07 | -18.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -74.1% | -51.8% | 0.04 | 4.62 | -18.2 |
| 31 Dec 2018 | FY | 100.0% | -150478.6% | -85.1% | -51.4% | 0.00 | 4.30 | -19.9 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -10.6% | -8.2% | 0.15 | 7.76 | -1.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -9.8% | -7.6% | 0.14 | 7.99 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -16.3% | -12.6% | 0.13 | 6.94 | -0.6 |
| 31 Dec 2024 | Q4 | 100.0% | -176.7% | -14.1% | -11.0% | 0.13 | 7.32 | -1.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -11.3% | -8.9% | 0.12 | 7.29 | -1.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -23.1% | -18.0% | 0.12 | 6.59 | -0.8 |
| 31 Mar 2024 | Q1 | 99.2% | 24.8% | 2.2% | 1.8% | 0.10 | 9.19 | 28.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -13.9% | -10.8% | 0.10 | 7.16 | -4.4 |